ÂÜÀòÂÒÂ×

Katarina Bartle serves as the Vice President of Quality at Entrada Therapeutics since July 2024, focusing on the evolution and scaling of quality assurance functions and the development of GxP systems. Prior to this role, Katarina held the position of Head of Global Quality at Amylyx Pharmaceuticals from May 2020 to June 2024, where responsibilities included building a global quality team and ensuring compliance with regulatory standards. Katarina's earlier experience encompasses senior leadership roles in quality assurance at Karyopharm Therapeutics Inc., Shire, and EMD Millipore, with a strong emphasis on overseeing manufacturing and quality operations across various pharmaceutical and biopharmaceutical contexts. Educational background includes studies at Bundeswehr University Munich.